Whitepaper

Whitepaper: Advancing drug discovery for neurodegenerative diseases

This whitepaper reviews the drug discovery progress for neurodegenerative diseases, focusing on promising candidates identified using iPSC technology.

The incidence of neurodegenerative diseases has been rising dramatically. However, currently available treatments don’t treat the root cause of the disease, but only attempt to alleviate symptoms or slow disease progression.

 

There is a clear need for alternative approaches for target identification in order to advance therapeutics with higher confidence through the pipeline. This whitepaper reviews the drug discovery progress for several neurodegenerative diseases, focusing on candidates identified using iPSC technology.